Alfred Sidney Barritt
University of North Carolina at Chapel Hill · 380 works · 10,594 citations · h-index 43
Top works
- Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
- Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
- Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
- A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis
- Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
- NAFLD and liver transplantation: Current burden and expected challenges
- Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
- COVID-19 and liver disease: mechanistic and clinical perspectives
- High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
- Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death
- Decreasing Mortality Among Patients Hospitalized With Cirrhosis in the United States From 2002 Through 2010
- Determining risk factors for mortality in liver transplant patients with COVID-19
- Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
- FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
- PATTERNS OF MORTALITY IN HOMES FOR THE ELDERLY
- Paracentesis Is Associated With Reduced Mortality in Patients Hospitalized With Cirrhosis and Ascites
- Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide
- Declining liver graft quality threatens the future of liver transplantation in the United States
- Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype
- Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus